{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:08:04Z","timestamp":1787069284357,"version":"build-2736575974"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12012-026-10167-y","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:53:04Z","timestamp":1785480784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual-Metal Regulation of Cardiac Remodeling: Targeting the LOXL2-Ferroptosis Axis in Metal-Induced Cardiac Dysfunction"],"prefix":"10.1007","volume":"26","author":[{"given":"Saif","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhi Bagwe","family":"Parab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4302-9300","authenticated-orcid":false,"given":"Lokesh Kumar","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"10167_CR1","doi-asserted-by":"publisher","unstructured":"Stark, B. A., DeCleene, N. K., Desai, E. C., Hsu, J. M., Johnson, C. O., Lara-Castor, L., \u2026 Roth, G. A. (2025). Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990\u20132023. JACC, 86(22), 2167\u20132243. https:\/\/doi.org\/10.1016\/j.jacc.2025.08.015","DOI":"10.1016\/j.jacc.2025.08.015"},{"key":"10167_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.886553","author":"K Schimmel","year":"2022","unstructured":"Schimmel, K., Ichimura, K., Reddy, S., Haddad, F., & Spiekerkoetter, E. (2022). Cardiac fibrosis in the pressure overloaded left and right ventricle as a therapeutic target. Frontiers in Cardiovascular Medicine. https:\/\/doi.org\/10.3389\/fcvm.2022.886553","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"7","key":"10167_CR3","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/CIRCRESAHA.124.325402","volume":"136","author":"R Ghazal","year":"2025","unstructured":"Ghazal, R., Wang, M., Liu, D., Tschumperlin, D. J., & Pereira, N. L. (2025). Cardiac fibrosis in the multi-omics era: Implications for heart failure. Circulation Research, 136(7), 773\u2013802. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.325402","journal-title":"Circulation Research"},{"issue":"3","key":"10167_CR4","doi-asserted-by":"publisher","first-page":"C694","DOI":"10.1152\/ajpcell.00176.2023","volume":"325","author":"A Poe","year":"2023","unstructured":"Poe, A., Martinez Yus, M., Wang, H., & Santhanam, L. (2023). Lysyl oxidase like-2 in fibrosis and cardiovascular disease. American Journal of Physiology-Cell Physiology, 325(3), C694\u2013C707. https:\/\/doi.org\/10.1152\/ajpcell.00176.2023","journal-title":"American Journal of Physiology-Cell Physiology"},{"issue":"1","key":"10167_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12964-020-00555-4","volume":"18","author":"F Yousefi","year":"2020","unstructured":"Yousefi, F., Shabaninejad, Z., Vakili, S., Derakhshan, M., Movahedpour, A., Dabiri, H., Ghasemi, Y., Mahjoubin-Tehran, M., Nikoozadeh, A., Savardashtaki, A., Mirzaei, H., & Hamblin, M. R. (2020). TGF-\u03b2 and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus. Cell Communication and Signaling, 18(1), 87. https:\/\/doi.org\/10.1186\/s12964-020-00555-4","journal-title":"Cell Communication and Signaling"},{"key":"10167_CR6","doi-asserted-by":"publisher","first-page":"1601261","DOI":"10.3389\/fonc.2025.1601261","volume":"15","author":"T Yang","year":"2025","unstructured":"Yang, T., Li, H., Zhou, W., Zhang, N., Tian, Z., Wang, H., Feng, Y., Chen, Y., & Wang, Z. (2025). Bibliometric analysis combined with visualization on universal trends and hot topics of LOX family in human diseases: 1995 to 2025. Frontiers in Oncology, 15, 1601261. https:\/\/doi.org\/10.3389\/fonc.2025.1601261","journal-title":"Frontiers in Oncology"},{"issue":"10","key":"10167_CR7","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1007\/s11010-025-05340-w","volume":"480","author":"P Chen","year":"2025","unstructured":"Chen, P., He, P., Rao, X., Ding, M., Liu, J., Chu, Y., & Xiao, Y. (2025). Emerging trends in cardiovascular diseases: The impact of ferroptosis and cuproptosis on cardiomyocyte death. Molecular and Cellular Biochemistry, 480(10), 5323\u20135344. https:\/\/doi.org\/10.1007\/s11010-025-05340-w","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"9","key":"10167_CR8","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3390\/cells11091399","volume":"11","author":"K Komai","year":"2022","unstructured":"Komai, K., Kawasaki, N. K., Higa, J. K., & Matsui, T. (2022). The role of ferroptosis in adverse left ventricular remodeling following acute myocardial infarction. Cells, 11(9), 1399. https:\/\/doi.org\/10.3390\/cells11091399","journal-title":"Cells"},{"key":"10167_CR9","doi-asserted-by":"publisher","first-page":"7675","DOI":"10.2147\/IJGM.S581227","volume":"18","author":"S Guo","year":"2025","unstructured":"Guo, S., Liu, J., Hua, J., Ding, L., & Chen, Q. (2025). Ferroptosis: The pivotal link in cardiovascular diseases pathogenesis and therapy. International Journal of General Medicine, 18, 7675\u20137697. https:\/\/doi.org\/10.2147\/IJGM.S581227","journal-title":"International Journal of General Medicine"},{"issue":"3","key":"10167_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1161\/CIRCRESAHA.122.321667","volume":"132","author":"KT Sawicki","year":"2023","unstructured":"Sawicki, K. T., De Jesus, A., & Ardehali, H. (2023). Iron metabolism in cardiovascular disease: Physiology, mechanisms, and therapeutic targets. Circulation Research, 132(3), 379\u2013396. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.321667","journal-title":"Circulation Research"},{"issue":"2","key":"10167_CR11","doi-asserted-by":"publisher","first-page":"C186","DOI":"10.1152\/ajpcell.00132.2018","volume":"315","author":"T Fukai","year":"2018","unstructured":"Fukai, T., Ushio-Fukai, M., & Kaplan, J. H. (2018). Copper transporters and copper chaperones: Roles in cardiovascular physiology and disease. American Journal of Physiology, Cell Physiology, 315(2), C186\u2013C201. https:\/\/doi.org\/10.1152\/ajpcell.00132.2018","journal-title":"American Journal of Physiology, Cell Physiology"},{"key":"10167_CR12","doi-asserted-by":"publisher","first-page":"1527901","DOI":"10.3389\/fphar.2024.1527901","volume":"15","author":"Z Liu","year":"2025","unstructured":"Liu, Z., Gan, Y., Shen, Z., Cai, S., Wang, X., Li, Y., Li, X., Fu, H., Chen, J., & Li, N. (2025). Role of copper homeostasis and cuproptosis in heart failure pathogenesis: implications for therapeutic strategies. Frontiers in Pharmacology, 15, 1527901. https:\/\/doi.org\/10.3389\/fphar.2024.1527901","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"10167_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030700","volume":"14","author":"Y Liu","year":"2022","unstructured":"Liu, Y., & Miao, J. (2022). An emerging role of defective copper metabolism in heart disease. Nutrients, 14(3), Article 700. https:\/\/doi.org\/10.3390\/nu14030700","journal-title":"Nutrients"},{"issue":"1","key":"10167_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01014-x","volume":"7","author":"S-R Li","year":"2022","unstructured":"Li, S.-R., Bu, L.-L., & Cai, L. (2022). Cuproptosis: Lipoylated TCA cycle proteins-mediated novel cell death pathway. Signal Transduction and Targeted Therapy, 7(1), Article 158. https:\/\/doi.org\/10.1038\/s41392-022-01014-x","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"5","key":"10167_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.21037\/cdt-22-214","volume":"12","author":"H-J Yuan","year":"2022","unstructured":"Yuan, H.-J., Xue, Y.-T., & Liu, Y. (2022). Cuproptosis, the novel therapeutic mechanism for heart failure: A narrative review. Cardiovascular Diagnosis and Therapy, 12(5), 681\u2013692. https:\/\/doi.org\/10.21037\/cdt-22-214","journal-title":"Cardiovascular Diagnosis and Therapy"},{"issue":"14","key":"10167_CR16","doi-asserted-by":"publisher","first-page":"6836","DOI":"10.1073\/pnas.1817473116","volume":"116","author":"V Shanbhag","year":"2019","unstructured":"Shanbhag, V., Jasmer-McDonald, K., Zhu, S., Martin, A. L., Gudekar, N., Khan, A., Ladomersky, E., Singh, K., Weisman, G. A., & Petris, M. J. (2019). ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis. Proceedings of the National Academy of Sciences, 116(14), 6836\u20136841. https:\/\/doi.org\/10.1073\/pnas.1817473116","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"16","key":"10167_CR17","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.3390\/ijms21165913","volume":"21","author":"M Erasmus","year":"2020","unstructured":"Erasmus, M., Samodien, E., Lecour, S., Cour, M., Lorenzo, O., Dludla, P., Pheiffer, C., & Johnson, R. (2020). Linking LOXL2 to cardiac interstitial fibrosis. International Journal of Molecular Sciences, 21(16), 5913. https:\/\/doi.org\/10.3390\/ijms21165913","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"10167_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.22038\/IJBMS.2022.63338.13981","volume":"25","author":"J Luo","year":"2022","unstructured":"Luo, J., Wu, Y., Zhu, X., Wang, S., Zhang, X., & Ning, Z. (2022). LOXL2 silencing suppresses angiotensin II-induced cardiac hypertrophy through the EMT process and TGF-\u03b21\/Smad3\/NF-\u03baB pathway. Iranian Journal of Basic Medical Sciences, 25(8), 964\u2013969. https:\/\/doi.org\/10.22038\/IJBMS.2022.63338.13981","journal-title":"Iranian Journal of Basic Medical Sciences"},{"key":"10167_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1611449","author":"Y Yang","year":"2025","unstructured":"Yang, Y., Liang, L., Pei, W., & Sun, Y. (2025). Interaction of ferroptosis and cuproptosis in the perspective of pulmonary hypertension. Frontiers in Cardiovascular Medicine. https:\/\/doi.org\/10.3389\/fcvm.2025.1611449","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10167_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1301822","author":"C Fu","year":"2023","unstructured":"Fu, C., Cao, N., Zeng, S., Zhu, W., Fu, X., Liu, W., & Fan, S. (2023). Role of mitochondria in the regulation of ferroptosis and disease. Frontiers in Medicine. https:\/\/doi.org\/10.3389\/fmed.2023.1301822","journal-title":"Frontiers in Medicine"},{"issue":"3","key":"10167_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/biology10030184","volume":"10","author":"J-Y Lee","year":"2021","unstructured":"Lee, J.-Y., Kim, W. K., Bae, K.-H., Lee, S. C., & Lee, E.-W. (2021). Lipid metabolism and ferroptosis. Biology, 10(3), Article 184. https:\/\/doi.org\/10.3390\/biology10030184","journal-title":"Biology"},{"issue":"2","key":"10167_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/lifemeta\/loac035","volume":"1","author":"J Guo","year":"2022","unstructured":"Guo, J., Zhou, Y., Liu, D., Wang, M., Wu, Y., Tang, D., & Liu, X. (2022). Mitochondria as multifaceted regulators of ferroptosis. Life Metabolism, 1(2), 134\u2013148. https:\/\/doi.org\/10.1093\/lifemeta\/loac035","journal-title":"Life Metabolism"},{"issue":"7","key":"10167_CR23","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1158\/1541-7786.MCR-18-0055","volume":"16","author":"Y-S Lee","year":"2018","unstructured":"Lee, Y.-S., Lee, D.-H., Choudry, H. A., Bartlett, D. L., & Lee, Y. J. (2018). Ferroptosis-induced endoplasmic reticulum stress: Cross-talk between ferroptosis and apoptosis. Molecular Cancer Research\u202f: MCR, 16(7), 1073\u20131076. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0055","journal-title":"Molecular Cancer Research : MCR"},{"issue":"1","key":"10167_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00018-025-05958-5","volume":"82","author":"K Duo","year":"2025","unstructured":"Duo, K., Feng, X., Tian, X., Wang, F., Zhao, Y., Yu, J., Liu, Y., He, Y., & Cai, Z. (2025). Ferroptosis inhibitors: mechanisms of action and therapeutic potential. Cellular and Molecular Life Sciences, 82(1), 441. https:\/\/doi.org\/10.1007\/s00018-025-05958-5","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"1","key":"10167_CR25","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1186\/s12967-024-05881-6","volume":"22","author":"Y Li","year":"2024","unstructured":"Li, Y., Liu, C., Fang, B., Chen, X., Wang, K., Xin, H., Wang, K., & Yang, S. M. (2024). Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer. Journal of Translational Medicine, 22(1), 1137. https:\/\/doi.org\/10.1186\/s12967-024-05881-6","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"10167_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13148-024-01809-5","volume":"17","author":"C Jing","year":"2025","unstructured":"Jing, C., Wu, Y., Zhang, Y., Zhu, Z., Zhang, Y., Liu, Z., & Sun, D. (2025). Epigenetic regulation and post-translational modifications of ferroptosis-related factors in cardiovascular diseases. Clinical Epigenetics, 17(1), 4. https:\/\/doi.org\/10.1186\/s13148-024-01809-5","journal-title":"Clinical Epigenetics"},{"issue":"1","key":"10167_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12933-025-02614-x","volume":"24","author":"Z Wang","year":"2025","unstructured":"Wang, Z., Wu, C., Yin, D., & Dou, K. (2025). Ferroptosis: Mechanism and role in diabetes-related cardiovascular diseases. Cardiovascular Diabetology, 24(1), 60. https:\/\/doi.org\/10.1186\/s12933-025-02614-x","journal-title":"Cardiovascular Diabetology"},{"issue":"3","key":"10167_CR28","doi-asserted-by":"publisher","first-page":"C694","DOI":"10.1152\/ajpcell.00176.2023","volume":"325","author":"A Poe","year":"2023","unstructured":"Poe, A., Martinez Yus, M., Wang, H., & Santhanam, L. (2023). Lysyl oxidase like-2 in fibrosis and cardiovascular disease. American Journal of Physiology, Cell Physiology, 325(3), C694\u2013C707. https:\/\/doi.org\/10.1152\/ajpcell.00176.2023","journal-title":"American Journal of Physiology, Cell Physiology"},{"key":"10167_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2026.2682046","author":"FC Mathias-Netto","year":"2026","unstructured":"Mathias-Netto, F. C., Cantu\u00e1ria, N. M., & Gaspar, R. S. (2026). Enzymatic and non-enzymatic oxidation of fibrillar collagen. Redox Report. https:\/\/doi.org\/10.1080\/13510002.2026.2682046","journal-title":"Redox Report"},{"issue":"1","key":"10167_CR30","doi-asserted-by":"publisher","first-page":"C298","DOI":"10.1152\/ajpcell.00913.2024","volume":"329","author":"B Zha","year":"2025","unstructured":"Zha, B., Zhang, C., & Wu, C. (2025). The stiffness of extracellular matrix in regulating cellular metabolism. American Journal of Physiology, Cell Physiology, 329(1), C298\u2013C306. https:\/\/doi.org\/10.1152\/ajpcell.00913.2024","journal-title":"American Journal of Physiology, Cell Physiology"},{"issue":"1","key":"10167_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/antiox15010070","volume":"15","author":"X Lin","year":"2026","unstructured":"Lin, X., Li, W., Ye, J., & Li, L. (2026). Ferroptosis in myocardial fibrosis: Mechanisms and therapeutic insights. Antioxidants, 15(1), Article 70. https:\/\/doi.org\/10.3390\/antiox15010070","journal-title":"Antioxidants"},{"issue":"4","key":"10167_CR32","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","volume":"127","author":"X Fang","year":"2020","unstructured":"Fang, X., Cai, Z., Wang, H., Han, D., Cheng, Q., Zhang, P., Gao, F., Yu, Y., Song, Z., Wu, Q., & An, P. (2020). Loss of cardiac Ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis. Circulation research, 127(4), 486\u2013501. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316509","journal-title":"Circulation research"},{"issue":"1","key":"10167_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41420-021-00579-w","volume":"7","author":"Y Yu","year":"2021","unstructured":"Yu, Y., Yan, Y., Niu, F., Wang, Y., Chen, X., Su, G., Liu, Y., Zhao, X., Qian, L., Liu, P., & Xiong, Y. (2021). Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discovery, 7(1), 193. https:\/\/doi.org\/10.1038\/s41420-021-00579-w","journal-title":"Cell Death Discovery"},{"issue":"1","key":"10167_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02088-5","volume":"10","author":"F Alves","year":"2025","unstructured":"Alves, F., Lane, D., Nguyen, T. P. M., Bush, A. I., & Ayton, S. (2025). In defence of ferroptosis. Signal Transduction and Targeted Therapy, 10(1), Article 2. https:\/\/doi.org\/10.1038\/s41392-024-02088-5","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10167_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1691705","author":"Z Wang","year":"2025","unstructured":"Wang, Z., Dang, Y., Li, Y., Zhang, Y., Zhou, S., Zhang, Z., & Wang, Y. (2025). Recent advances in the interaction of ferroptosis and immune-mediated inflammation in cardiovascular disease: Mechanisms and therapeutic potential. Frontiers in Immunology. https:\/\/doi.org\/10.3389\/fimmu.2025.1691705","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10167_CR36","doi-asserted-by":"publisher","first-page":"13710","DOI":"10.1038\/ncomms13710","volume":"7","author":"J Yang","year":"2016","unstructured":"Yang, J., Savvatis, K., Kang, J. S., Fan, P., Zhong, H., Schwartz, K., Barry, V., Mikels-Vigdal, A., Karpinski, S., Kornyeyev, D., & Adamkewicz, J. (2016). Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nature Communications, 7(1), 13710. https:\/\/doi.org\/10.1038\/ncomms13710","journal-title":"Nature Communications"},{"issue":"3","key":"10167_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cmet.2013.02.004","volume":"17","author":"W Xu","year":"2013","unstructured":"Xu, W., Barrientos, T., & Andrews, N. C. (2013). Iron and copper in mitochondrial diseases. Cell Metabolism, 17(3), 319\u2013328. https:\/\/doi.org\/10.1016\/j.cmet.2013.02.004","journal-title":"Cell Metabolism"},{"issue":"21","key":"10167_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213464","volume":"11","author":"MY Ali","year":"2022","unstructured":"Ali, M. Y., Oliva, C. R., Flor, S., & Griguer, C. E. (2022). Mitoferrin, cellular and mitochondrial iron homeostasis. Cells, 11(21), Article 3464. https:\/\/doi.org\/10.3390\/cells11213464","journal-title":"Cells"},{"issue":"16","key":"10167_CR39","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1089\/ars.2012.4847","volume":"19","author":"M Bourens","year":"2013","unstructured":"Bourens, M., Fontanesi, F., Soto, I. C., Liu, J., & Barrientos, A. (2013). Redox and reactive oxygen species regulation of mitochondrial cytochrome c oxidase biogenesis. Antioxidants & Redox Signaling, 19(16), 1940\u20131952. https:\/\/doi.org\/10.1089\/ars.2012.4847","journal-title":"Antioxidants & Redox Signaling"},{"issue":"6586","key":"10167_CR40","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P., Coy, S., Petrova, B., Dreishpoon, M., Verma, A., Abdusamad, M., Rossen, J., Joesch-Cohen, L., Humeidi, R., Spangler, R. D., & Eaton, J. K. (2022). Copper induces cell death by targeting lipoylated TCA cycle proteins. Science, 375(6586), 1254\u20131261. https:\/\/doi.org\/10.1126\/science.abf0529","journal-title":"Science"},{"key":"10167_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121483","author":"C Rodr\u00edguez","year":"2019","unstructured":"Rodr\u00edguez, C., & Mart\u00ednez-Gonz\u00e1lez, J. (2019). The role of lysyl oxidase enzymes in cardiac function and remodeling. Cells. https:\/\/doi.org\/10.3390\/cells8121483","journal-title":"Cells"},{"key":"10167_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz176","author":"D Al-u\u2019datt","year":"2019","unstructured":"Al-u\u2019datt, D., Allen, B. G., & Nattel, S. (2019). Role of the lysyl oxidase enzyme family in cardiac function and disease. Cardiovascular Research. https:\/\/doi.org\/10.1093\/cvr\/cvz176","journal-title":"Cardiovascular Research"},{"issue":"1","key":"10167_CR43","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/19768354.2026.2623320","volume":"30","author":"T Kim","year":"2026","unstructured":"Kim, T., Wang, Y., & Suh, N. (2026). MicroRNA-mediated mechanotransduction and chondrocyte differentiation in mesenchymal stem cells. Animal Cells and Systems, 30(1), 201\u2013218. https:\/\/doi.org\/10.1080\/19768354.2026.2623320","journal-title":"Animal Cells and Systems"},{"issue":"8","key":"10167_CR44","doi-asserted-by":"publisher","first-page":"e70281","DOI":"10.1002\/mco2.70281","volume":"6","author":"T Zhao","year":"2025","unstructured":"Zhao, T., Huang, Y., Zhu, J., Qin, Y., Wu, H., Yu, J., Zhai, Q., Li, S., Qin, X., Wang, D., & Li, T. (2025). Extracellular matrix signaling cues: Biological functions, diseases, and therapeutic targets. MedComm, 6(8), e70281. https:\/\/doi.org\/10.1002\/mco2.70281","journal-title":"MedComm"},{"issue":"4","key":"10167_CR45","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/jleuko\/qiae113","volume":"116","author":"V Kain","year":"2024","unstructured":"Kain, V., Grilo, G. A., Upadhyay, G., Nadler, J. L., Serhan, C. N., & Halade, G. V. (2024). Macrophage-specific lipoxygenase deletion amplify cardiac repair activating Treg cells in chronic heart failure. Journal of Leukocyte Biology, 116(4), 864\u2013875. https:\/\/doi.org\/10.1093\/jleuko\/qiae113","journal-title":"Journal of Leukocyte Biology"},{"issue":"7","key":"10167_CR46","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1084\/jem.20082596","volume":"206","author":"Y Kayama","year":"2009","unstructured":"Kayama, Y., Minamino, T., Toko, H., Sakamoto, M., Shimizu, I., Takahashi, H., Okada, S., Tateno, K., Moriya, J., Yokoyama, M., & Nojima, A. (2009). Cardiac 12\/15 lipoxygenase\u2013induced inflammation is involved in heart failure. Journal of Experimental Medicine, 206(7), 1565\u20131574. https:\/\/doi.org\/10.1084\/jem.20082596","journal-title":"Journal of Experimental Medicine"},{"issue":"3","key":"10167_CR47","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5483\/BMBRep.2023-0002","volume":"56","author":"Y-J Kim","year":"2023","unstructured":"Kim, Y.-J., & Hyun, J. (2023). Mechanosensitive ion channels in apoptosis and ferroptosis: Focusing on the role of Piezo1. BMB Reports, 56(3), 145\u2013152. https:\/\/doi.org\/10.5483\/BMBRep.2023-0002","journal-title":"BMB Reports"},{"issue":"9","key":"10167_CR48","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.tcb.2022.05.005","volume":"32","author":"S Magesh","year":"2022","unstructured":"Magesh, S., & Cai, D. (2022). Roles of YAP\/TAZ in ferroptosis. Trends in Cell Biology, 32(9), 729\u2013732. https:\/\/doi.org\/10.1016\/j.tcb.2022.05.005","journal-title":"Trends in Cell Biology"},{"issue":"4","key":"10167_CR49","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/ph11040114","volume":"11","author":"N Santana-Codina","year":"2018","unstructured":"Santana-Codina, N., & Mancias, J. D. (2018). The role of NCOA4-mediated ferritinophagy in health and disease. Pharmaceuticals, 11(4), 114. https:\/\/doi.org\/10.3390\/ph11040114","journal-title":"Pharmaceuticals"},{"key":"10167_CR50","doi-asserted-by":"publisher","unstructured":"Yan, J., Zhang, Z., Ge, Y., Chen, J., Xu, H., Gao, R., Huang, M., Xiao, C., Zhang, H., Gao, Y., & Zhang, B. (2024). ALOX15 knockdown mitigates hypoxia and hypobaric-induced heart injury and ferroptosis via p53-SAT1 signaling pathway. https:\/\/doi.org\/10.21203\/rs.3.rs-4627119\/v1","DOI":"10.21203\/rs.3.rs-4627119\/v1"},{"key":"10167_CR51","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.2147\/JIR.S358470","volume":"15","author":"J Zhou","year":"2022","unstructured":"Zhou, J., Tan, Y., Wang, R., & Li, X. (2022). Role of ferroptosis in fibrotic diseases. Journal of Inflammation Research, 15, 3689\u20133708. https:\/\/doi.org\/10.2147\/JIR.S358470","journal-title":"Journal of Inflammation Research"},{"issue":"5","key":"10167_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2025.13483","volume":"31","author":"D Wang","year":"2025","unstructured":"Wang, D., Qu, X., Zhang, Z., & Zhou, G. (2025). New developments in the role of ferroptosis in sepsis-induced cardiomyopathy (Review). Molecular Medicine Reports, 31(5), 1\u201312. https:\/\/doi.org\/10.3892\/mmr.2025.13483","journal-title":"Molecular Medicine Reports"},{"key":"10167_CR53","doi-asserted-by":"publisher","unstructured":"Kraft, V. A. N., Bezjian, C. T., Pfeiffer, S., Ringelstetter, L., M\u00fcller, C., Zandkarimi, F., \u2026 Schick, J. A. (2020). GTP Cyclohydrolase 1\/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling. ACS Central Science, 6(1), 41\u201353. https:\/\/doi.org\/10.1021\/acscentsci.9b01063","DOI":"10.1021\/acscentsci.9b01063"},{"issue":"1","key":"10167_CR54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/cvr\/cvv214","volume":"109","author":"J Gonz\u00e1lez-Santamar\u00eda","year":"2016","unstructured":"Gonz\u00e1lez-Santamar\u00eda, J., Villalba, M., Busnadiego, O., L\u00f3pez-Ola\u00f1eta, M. M., Sandoval, P., Snabel, J., L\u00f3pez-Cabrera, M., Erler, J. T., Hanemaaijer, R., Lara-Pezzi, E., & Rodr\u00edguez-Pascual, F. (2016). Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction. Cardiovascular Research, 109(1), 67\u201378. https:\/\/doi.org\/10.1093\/cvr\/cvv214","journal-title":"Cardiovascular Research"},{"issue":"1","key":"10167_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cyto.2011.03.024","volume":"55","author":"TG Voloshenyuk","year":"2011","unstructured":"Voloshenyuk, T. G., Landesman, E. S., Khoutorova, E., Hart, A. D., & Gardner, J. D. (2011). Induction of cardiac fibroblast lysyl oxidase by TGF-\u03b21 requires PI3K\/Akt, Smad3, and MAPK signaling. Cytokine, 55(1), 90\u201397. https:\/\/doi.org\/10.1016\/j.cyto.2011.03.024","journal-title":"Cytokine"},{"issue":"1","key":"10167_CR56","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s40001-024-01809-4","volume":"29","author":"T Zhang","year":"2024","unstructured":"Zhang, T., Luo, L., He, Q., Xiao, S., Li, Y., Chen, J., Qin, T., Xiao, Z., & Ge, Q. (2024). Research advances on molecular mechanism and natural product therapy of iron metabolism in heart failure. European Journal of Medical Research, 29(1), 253. https:\/\/doi.org\/10.1186\/s40001-024-01809-4","journal-title":"European Journal of Medical Research"},{"key":"10167_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110354","volume":"129","author":"Z Zheng","year":"2020","unstructured":"Zheng, Z., Li, Y., Jin, G., Huang, T., Zou, M., & Duan, S. (2020). The biological role of arachidonic acid 12-lipoxygenase (ALOX12) in various human diseases. Biomedicine & Pharmacotherapy, 129, Article 110354. https:\/\/doi.org\/10.1016\/j.biopha.2020.110354","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"10167_CR58","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13578-023-01169-2","volume":"13","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q., Luo, Y., Peng, L., Rong, X., Liu, Y., Li, J., & Luo, J. (2023). Ferroptosis in cardiovascular diseases: Role and mechanism. Cell & Bioscience, 13(1), 226. https:\/\/doi.org\/10.1186\/s13578-023-01169-2","journal-title":"Cell & Bioscience"},{"issue":"19","key":"10167_CR59","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/CIRCULATIONAHA.122.060257","volume":"147","author":"W Cai","year":"2023","unstructured":"Cai, W., Liu, L., Shi, X., Liu, Y., Wang, J., Fang, X., Chen, Z., Ai, D., Zhu, Y., & Zhang, X. (2023). Alox15\/15-HpETE aggravates myocardial ischemia-reperfusion injury by promoting cardiomyocyte ferroptosis. Circulation, 147(19), 1444\u20131460. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.060257","journal-title":"Circulation"},{"issue":"7\u20139","key":"10167_CR60","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1089\/ars.2023.0468","volume":"43","author":"X Sun","year":"2025","unstructured":"Sun, X., Chen, L., Han, J., Cai, W., Li, S., Chen, T., Chen, M., Zhang, H., He, Y., Zheng, L., & Wang, L. (2025). ALOX15 modulates ferroptosis via the reactive oxygen species-mediated MAPK pathway in doxorubicin-induced cardiotoxicity. Antioxidants & Redox Signaling, 43(7\u20139), 363\u2013380. https:\/\/doi.org\/10.1089\/ars.2023.0468","journal-title":"Antioxidants & Redox Signaling"},{"issue":"1","key":"10167_CR61","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41392-022-01090-z","volume":"7","author":"XH Ma","year":"2022","unstructured":"Ma, X. H., Liu, J. H. Z., Liu, C. Y., Sun, W. Y., Duan, W. J., Wang, G., Kurihara, H., He, R. R., Li, Y. F., Chen, Y., & Shang, H. (2022). ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage. Signal Transduction and Targeted Therapy, 7(1), 288. https:\/\/doi.org\/10.1038\/s41392-022-01090-z","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10167_CR62","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12916-019-1469-4","volume":"18","author":"X Hua","year":"2020","unstructured":"Hua, X., Wang, Y. Y., Jia, P., Xiong, Q., Hu, Y., Chang, Y., Lai, S., Xu, Y., Zhao, Z., & Song, J. (2020). Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression. BMC Medicine, 18(1), 2. https:\/\/doi.org\/10.1186\/s12916-019-1469-4","journal-title":"BMC Medicine"},{"issue":"1","key":"10167_CR63","doi-asserted-by":"publisher","first-page":"13710","DOI":"10.1038\/ncomms13710","volume":"7","author":"J Yang","year":"2016","unstructured":"Yang, J., Savvatis, K., Kang, J. S., Fan, P., Zhong, H., Schwartz, K., Barry, V., Mikels-Vigdal, A., Karpinski, S., Kornyeyev, D., Adamkewicz, J., & Chang, C.-P. (2016). Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nature Communications, 7(1), 13710. https:\/\/doi.org\/10.1038\/ncomms13710","journal-title":"Nature Communications"},{"issue":"1","key":"10167_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05759-7","volume":"22","author":"C Hou","year":"2024","unstructured":"Hou, C., Huo, J., Yan, S., Sun, F., & Yang, X. (2024). Identification of fibrosis-associated biomarkers in heart failure and human cancers. Journal of Translational Medicine, 22(1), Article 1042. https:\/\/doi.org\/10.1186\/s12967-024-05759-7","journal-title":"Journal of Translational Medicine"},{"issue":"6","key":"10167_CR65","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","volume":"117","author":"NG Frangogiannis","year":"2021","unstructured":"Frangogiannis, N. G. (2021). Cardiac fibrosis. Cardiovascular Research, 117(6), 1450\u20131488. https:\/\/doi.org\/10.1093\/cvr\/cvaa324","journal-title":"Cardiovascular Research"},{"issue":"11","key":"10167_CR66","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s10495-025-02192-z","volume":"30","author":"Y Li","year":"2025","unstructured":"Li, Y., Lou, Z., Liu, F., Liu, Y., Wang, C., Wang, Y., Qian, W., Li, D., & Xu, T. (2025). The impact of lipid metabolism on ferroptosis in myocardial ischemia\u2013reperfusion injury. Apoptosis, 30(11), 2761\u20132775. https:\/\/doi.org\/10.1007\/s10495-025-02192-z","journal-title":"Apoptosis"},{"issue":"3","key":"10167_CR67","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1111\/jcmm.14074","volume":"23","author":"H Schilter","year":"2019","unstructured":"Schilter, H., Findlay, A. D., Perryman, L., Yow, T. T., Moses, J., Zahoor, A., Turner, C. I., Deodhar, M., Foot, J. S., Zhou, W., Greco, A., & Jarolimek, W. (2019). The lysyl oxidase like 2\/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis. Journal of Cellular and Molecular Medicine, 23(3), 1759\u20131770. https:\/\/doi.org\/10.1111\/jcmm.14074","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"10167_CR68","doi-asserted-by":"publisher","first-page":"72","DOI":"10.22038\/ijbms.2024.79933.17317","volume":"28","author":"J Gu","year":"2025","unstructured":"Gu, J., Sun, H., Shao, J., Zhang, H., Zhu, Z., Ma, D., & Duan, Y. (2025). Lysyl oxidase-like 2 promotes the survival, migration, and ferroptosis of endometrial cancer cells by activating the phosphoinositide 3-kinase\/protein kinase B pathway. Iranian Journal of Basic Medical Sciences, 28(1), 72\u201379. https:\/\/doi.org\/10.22038\/ijbms.2024.79933.17317","journal-title":"Iranian Journal of Basic Medical Sciences"},{"issue":"6","key":"10167_CR69","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.7150\/ijbs.126580","volume":"22","author":"X Yu","year":"2026","unstructured":"Yu, X., Yuan, D., Wang, Y., Wang, L., Zhu, L., An, Q., & Ling, Y. (2026). Role of copper homeostasis and cuproptosis in cardiovascular disease: Molecular insights and metabolic perspectives. International Journal of Biological Sciences, 22(6), 2842\u20132868. https:\/\/doi.org\/10.7150\/ijbs.126580","journal-title":"International Journal of Biological Sciences"},{"issue":"3","key":"10167_CR70","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/molecules31030394","volume":"31","author":"S Wang","year":"2026","unstructured":"Wang, S., Zhang, J., & Zhou, Y. (2026). Cuproptosis: Biomarkers, mechanisms and treatments in diseases. Molecules, 31(3), 394. https:\/\/doi.org\/10.3390\/molecules31030394","journal-title":"Molecules"},{"issue":"16","key":"10167_CR71","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S1359-6446(05)03541-5","volume":"10","author":"GJ Brewer","year":"2005","unstructured":"Brewer, G. J. (2005). Anticopper therapy against cancer and diseases of inflammation and fibrosis. Drug Discovery Today, 10(16), 1103\u20131109. https:\/\/doi.org\/10.1016\/S1359-6446(05)03541-5","journal-title":"Drug Discovery Today"},{"issue":"9","key":"10167_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ph15091145","volume":"15","author":"FF Ramli","year":"2022","unstructured":"Ramli, F. F., Hashim, S. A. S., Raman, B., Mahmod, M., & Kamisah, Y. (2022). Role of trientine in hypertrophic cardiomyopathy: A review of mechanistic aspects. Pharmaceuticals, 15(9), Article 1145. https:\/\/doi.org\/10.3390\/ph15091145","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10167_CR73","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3390\/biom15091320","volume":"15","author":"M El-Nablaway","year":"2025","unstructured":"El-Nablaway, M., Sonpol, H. M., Elewa, Y. H. A., Ali, M. A., Adel, M., Zayed, E. S., Alhelf, M., Didamoony, M. A., Dawood, A. F., Embaby, E. M., El-Bayoumi, K. S., & El-Saeed, W. S. (2025). Copper chelation by Penicillamine protects against doxorubicin-induced cardiomyopathy by suppressing FDX1-mediated cuproptosis. Biomolecules, 15(9), 1320. https:\/\/doi.org\/10.3390\/biom15091320","journal-title":"Biomolecules"},{"issue":"1","key":"10167_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02044-w","volume":"10","author":"FI Gawargi","year":"2024","unstructured":"Gawargi, F. I., & Mishra, P. K. (2024). Regulation of cardiac ferroptosis in diabetic human heart failure: Uncovering molecular pathways and key targets. Cell Death Discovery, 10(1), Article 268. https:\/\/doi.org\/10.1038\/s41420-024-02044-w","journal-title":"Cell Death Discovery"},{"issue":"16","key":"10167_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612846","volume":"24","author":"J Laukaitiene","year":"2023","unstructured":"Laukaitiene, J., Gujyte, G., & Kadusevicius, E. (2023). Cardiomyocyte damage: Ferroptosis relation to ischemia-reperfusion injury and future treatment options. International Journal of Molecular Sciences, 24(16), Article 12846. https:\/\/doi.org\/10.3390\/ijms241612846","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10167_CR76","doi-asserted-by":"publisher","first-page":"e132747","DOI":"10.1172\/jci.insight.132747","volume":"5","author":"T Tadokoro","year":"2020","unstructured":"Tadokoro, T., Ikeda, M., Ide, T., Deguchi, H., Ikeda, S., Okabe, K., Ishikita, A., Matsushima, S., Koumura, T., Yamada, K. I., Imai, H., & Tsutsui, H. (2020). Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight, 5(9), e132747. https:\/\/doi.org\/10.1172\/jci.insight.132747","journal-title":"JCI Insight"},{"issue":"2","key":"10167_CR77","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/JCI72931","volume":"124","author":"Y Ichikawa","year":"2014","unstructured":"Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., \u2026 Ardehali, H. (2014). Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. Journal of Clinical Investigation, 124(2), 617\u2013630. https:\/\/doi.org\/10.1172\/JCI72931","journal-title":"Journal of Clinical Investigation"},{"key":"10167_CR78","doi-asserted-by":"publisher","unstructured":"Zhang, H., Wang, Z., Liu, Z., Du, K., & Lu, X. (2021). Protective Effects of Dexazoxane on Rat Ferroptosis in Doxorubicin-Induced Cardiomyopathy Through Regulating HMGB1. Frontiers in Cardiovascular Medicine, 8. https:\/\/doi.org\/10.3389\/fcvm.2021.685434","DOI":"10.3389\/fcvm.2021.685434"},{"key":"10167_CR79","doi-asserted-by":"publisher","unstructured":"Tian, M., Huang, X., Li, M., Lou, P., Ma, H., Jiang, X., \u2026 Liu, Y. (2024). Ferroptosis in diabetic cardiomyopathy: from its mechanisms to therapeutic strategies. Frontiers in Endocrinology, 15. https:\/\/doi.org\/10.3389\/fendo.2024.1421838","DOI":"10.3389\/fendo.2024.1421838"},{"key":"10167_CR80","doi-asserted-by":"publisher","unstructured":"Jin, B., Zhang, Z., Zhang, Y., Yang, M., Wang, C., Xu, J., \u2026 Sun, Z. (2024). Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives. Frontiers in Pharmacology, 15. https:\/\/doi.org\/10.3389\/fphar.2024.1482986","DOI":"10.3389\/fphar.2024.1482986"},{"issue":"1","key":"10167_CR81","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41392-024-01962-6","volume":"9","author":"X Bi","year":"2024","unstructured":"Bi, X., Wu, X., Chen, J., Li, X., Lin, Y., Yu, Y., \u2026 Wang, F. (2024). Characterization of ferroptosistriggered pyroptotic signaling in heart failure. Signal Transduction and Targeted Therapy, 9(1), 257. https:\/\/doi.org\/10.1038\/s41392-024-01962-6","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"8","key":"10167_CR82","doi-asserted-by":"publisher","first-page":"e70016","DOI":"10.1111\/cpr.70016","volume":"58","author":"C Li","year":"2025","unstructured":"Li, C., Li, D., Cheng, X., Yuan, X., Du, N., Liao, X., Feng, X., Yao, J., Li, C., Xie, C., & Yang, M. (2025). Elevated COMMD1 contributes to cardiomyocyte copper efflux in chronic myocardial ischemia: insights from rhesus monkey. Cell Proliferation, 58(8), e70016. https:\/\/doi.org\/10.1111\/cpr.70016","journal-title":"Cell Proliferation"},{"key":"10167_CR83","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pharmthera.2014.11.014","volume":"148","author":"L Zheng","year":"2015","unstructured":"Zheng, L., Han, P., Liu, J., Li, R., Yin, W., Wang, T., Zhang, W., & Kang, Y. J. (2015). Role of copper in regression of cardiac hypertrophy. Pharmacology & Therapeutics, 148, 66\u201384. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.11.014","journal-title":"Pharmacology & Therapeutics"},{"key":"10167_CR84","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.actbio.2022.08.063","volume":"152","author":"S Ragazzini","year":"2022","unstructured":"Ragazzini, S., Scocozza, F., Bernava, G., Auricchio, F., Colombo, G. I., Barbuto, M., Conti, M., Pesce, M., & Garoffolo, G. (2022). Mechanosensor YAP cooperates with TGF-\u03b21 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis. Acta Biomaterialia, 152, 300\u2013312. https:\/\/doi.org\/10.1016\/j.actbio.2022.08.063","journal-title":"Acta Biomaterialia"},{"key":"10167_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1174817","author":"L Xia","year":"2023","unstructured":"Xia, L., Shen, Y., Liu, S., & Du, J. (2023). Iron overload triggering ECM-mediated Hippo\/YAP pathway in follicle development: a hypothetical model endowed with therapeutic implications. Frontiers in Endocrinology. https:\/\/doi.org\/10.3389\/fendo.2023.1174817","journal-title":"Frontiers in Endocrinology"},{"key":"10167_CR86","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2022.01.020","volume":"181","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z., Tang, J., Song, J., Xie, M., Liu, Y., Dong, Z., Liu, X., Li, X., Zhang, M., Chen, Y., Shi, H., & Zhong, J. (2022). Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6\/STAT3\/GPX4 signaling. Free Radical Biology and Medicine, 181, 130\u2013142. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.01.020","journal-title":"Free Radical Biology and Medicine"},{"issue":"9","key":"10167_CR87","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen, X., Li, J., Kang, R., Klionsky, D. J., & Tang, D. (2021). Ferroptosis: Machinery and regulation. Autophagy, 17(9), 2054\u20132081. https:\/\/doi.org\/10.1080\/15548627.2020.1810918","journal-title":"Autophagy"},{"issue":"24","key":"10167_CR88","doi-asserted-by":"publisher","first-page":"11917","DOI":"10.3390\/ijms262411917","volume":"26","author":"HR Yun","year":"2025","unstructured":"Yun, H. R., Singh, M. K., Han, S., Ranbhise, J. S., Ha, J., Kim, S. S., & Kang, I. (2025). Integrating senescence and oxidative stress in cardiac disease. International Journal of Molecular Sciences, 26(24), 11917. https:\/\/doi.org\/10.3390\/ijms262411917","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10167_CR89","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bbrc.2019.01.090","volume":"510","author":"Q Wen","year":"2019","unstructured":"Wen, Q., Liu, J., Kang, R., Zhou, B., & Tang, D. (2019). The release and activity of HMGB1 in ferroptosis. Biochemical and Biophysical Research Communications, 510(2), 278\u2013283. https:\/\/doi.org\/10.1016\/j.bbrc.2019.01.090","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"7","key":"10167_CR90","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.hlc.2016.12.002","volume":"26","author":"EY Plotnikov","year":"2017","unstructured":"Plotnikov, E. Y., Silachev, D. N., Popkov, V. A., Zorova, L. D., Pevzner, I. B., Zorov, S. D., Jankauskas, S. S., Babenko, V. A., Sukhikh, G. T., & Zorov, D. B. (2017). Intercellular signalling cross-talk: To kill, to heal and to rejuvenate. Heart, Lung and Circulation, 26(7), 648\u2013659. https:\/\/doi.org\/10.1016\/j.hlc.2016.12.002","journal-title":"Heart, Lung and Circulation"},{"issue":"1","key":"10167_CR91","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2024.5457","volume":"55","author":"S Qin","year":"2024","unstructured":"Qin, S., Zhu, C., Chen, C., Sheng, Z., & Cao, Y. (2024). An emerging double-edged sword role of ferroptosis in cardiovascular disease (review). International Journal of Molecular Medicine, 55(1), Article 16. https:\/\/doi.org\/10.3892\/ijmm.2024.5457","journal-title":"International Journal of Molecular Medicine"},{"issue":"5\u20136","key":"10167_CR92","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s10495-023-01927-0","volume":"29","author":"J Gu","year":"2024","unstructured":"Gu, J., Guo, C., Ruan, J., Li, K., Zhou, Y., Gong, X., & Shi, H. (2024). From ferroptosis to cuproptosis, and calcicoptosis, to find more novel metals-mediated distinct form of regulated cell death. Apoptosis, 29(5\u20136), 586\u2013604. https:\/\/doi.org\/10.1007\/s10495-023-01927-0","journal-title":"Apoptosis"},{"issue":"1","key":"10167_CR93","doi-asserted-by":"publisher","first-page":"e031219","DOI":"10.1161\/JAHA.123.031219","volume":"13","author":"K Ishimaru","year":"2024","unstructured":"Ishimaru, K., Ikeda, M., Miyamoto, H. D., Furusawa, S., Abe, K., Watanabe, M., Kanamura, T., Fujita, S., Nishimura, R., Toyohara, T., Matsushima, S., & Ide, T. (2024). Deferasirox targeting ferroptosis synergistically ameliorates myocardial ischemia reperfusion injury in conjunction with Cyclosporine A. Journal of the American Heart Association, 13(1), e031219. https:\/\/doi.org\/10.1161\/JAHA.123.031219","journal-title":"Journal of the American Heart Association"},{"issue":"3","key":"10167_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/nu15030591","volume":"15","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Li, X., Wang, S., Miao, R., & Zhong, J. (2023). Targeting iron metabolism and ferroptosis as novel therapeutic approaches in cardiovascular diseases. Nutrients, 15(3), Article 591. https:\/\/doi.org\/10.3390\/nu15030591","journal-title":"Nutrients"},{"issue":"6","key":"10167_CR95","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.bjp.0707294","volume":"151","author":"D Lebrecht","year":"2007","unstructured":"Lebrecht, D., Geist, A., Ketelsen, U., Haberstroh, J., Setzer, B., & Walker, U. A. (2007). Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats. British Journal of Pharmacology, 151(6), 771\u2013778. https:\/\/doi.org\/10.1038\/sj.bjp.0707294","journal-title":"British Journal of Pharmacology"},{"key":"10167_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.685434","author":"H Zhang","year":"2021","unstructured":"Zhang, H., Wang, Z., Liu, Z., Du, K., & Lu, X. (2021). Protective effects of dexazoxane on rat ferroptosis in doxorubicin-induced cardiomyopathy through regulating HMGB1. Frontiers in Cardiovascular Medicine. https:\/\/doi.org\/10.3389\/fcvm.2021.685434","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"1","key":"10167_CR97","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1749-6632.2010.05591.x","volume":"1202","author":"R Galanello","year":"2010","unstructured":"Galanello, R., Agus, A., Campus, S., Danjou, F., Giardina, P. J., & Grady, R. W. (2010). Combined iron chelation therapy. Annals of the New York Academy of Sciences, 1202(1), 79\u201386. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05591.x","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10167_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2023.02.018","volume":"200","author":"M Lupu","year":"2023","unstructured":"Lupu, M., Coada, C. A., Tudor, D. V., Baldea, I., Florea, A., Toma, V. A., Lupsor, A., Moldovan, R., Decea, N., & Filip, G. A. (2023). Iron chelation alleviates multiple pathophysiological pathways in a rat model of cardiac pressure overload. Free Radical Biology and Medicine, 200, 1\u201310. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.02.018","journal-title":"Free Radical Biology and Medicine"},{"issue":"2","key":"10167_CR99","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1165\/rcmb.2020-0279OC","volume":"65","author":"Y Zhu","year":"2021","unstructured":"Zhu, Y., Chang, J., Tan, K., Huang, S. K., Liu, X., Wang, X., Cao, M., Zhang, H., Li, S., Duan, X., Chang, Y., & Cao, P. (2021). Clioquinol attenuates pulmonary fibrosis through inactivation of fibroblasts via iron chelation. American Journal of Respiratory Cell and Molecular Biology, 65(2), 189\u2013200. https:\/\/doi.org\/10.1165\/rcmb.2020-0279OC","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10167_CR100","doi-asserted-by":"publisher","unstructured":"Ishimaru, K., Ikeda, M., Miyamoto, H. D., Furusawa, S., Abe, K., Watanabe, M., \u2026 Ide, T. (2024). Deferasirox targeting ferroptosis synergistically ameliorates myocardial ischemia reperfusion injury in conjunction with cyclosporine A. Journal of the American Heart Association, 13(1). https:\/\/doi.org\/10.1161\/JAHA.123.031219","DOI":"10.1161\/JAHA.123.031219"},{"key":"10167_CR101","doi-asserted-by":"publisher","unstructured":"Zhang, H., Wang, Z., Liu, Z., Du, K., & Lu, X. (2021). Protective effects of dexazoxane on rat ferroptosis in doxorubicin-induced cardiomyopathy through regulating HMGB1. Frontiers in Cardiovascular Medicine, 8. https:\/\/doi.org\/10.3389\/fcvm.2021.685434","DOI":"10.3389\/fcvm.2021.685434"},{"issue":"1","key":"10167_CR102","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41420-024-02078-0","volume":"10","author":"Y Hu","year":"2024","unstructured":"Hu, Y., Huang, Y., Zong, L., Lin, J., Liu, X., & Ning, S. (2024). Emerging roles of ferroptosis in pulmonary fibrosis: current perspectives, opportunities and challenges. Cell Death Discovery, 10(1), 301. https:\/\/doi.org\/10.1038\/s41420-024-02078-0","journal-title":"Cell Death Discovery"},{"issue":"3","key":"10167_CR103","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/nu15030591","volume":"15","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Li, X., Wang, S., Miao, R., & Zhong, J. (2023). Targeting iron metabolism and ferroptosis as novel therapeutic approaches in cardiovascular diseases. Nutrients, 15(3), 591. https:\/\/doi.org\/10.3390\/nu15030591","journal-title":"Nutrients"},{"key":"10167_CR104","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S35478","author":"V Pullarkat","year":"2013","unstructured":"Pullarkat, V., & Chaudhary, P. (2013). Deferasirox: Appraisal of safety and efficacy in long-term therapy. Journal of Blood Medicine. https:\/\/doi.org\/10.2147\/JBM.S35478","journal-title":"Journal of Blood Medicine"},{"issue":"11","key":"10167_CR105","doi-asserted-by":"publisher","first-page":"e008209","DOI":"10.1161\/CIRCHEARTFAILURE.120.008209","volume":"14","author":"E Jirkovsk\u00fd","year":"2021","unstructured":"Jirkovsk\u00fd, E., Jirkovsk\u00e1, A., Bavlovi\u010d-Pisk\u00e1\u010dkov\u00e1, H., Skalick\u00e1, V., Pokorn\u00e1, Z., Karabanovich, G., Koll\u00e1rov\u00e1-Br\u00e1zdov\u00e1, P., Kube\u0161, J., Len\u010dov\u00e1-Popelov\u00e1, O., Mazurov\u00e1, Y., Adamcov\u00e1, M., & \u0160t\u011brba, M. (2021). Clinically translatable prevention of anthracycline cardiotoxicity by dexrazoxane is mediated by topoisomerase II beta and not metal chelation. Circulation: Heart Failure, 14(11), e008209. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.008209","journal-title":"Circulation: Heart Failure"},{"issue":"7","key":"10167_CR106","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2165\/00003495-200565070-00008","volume":"65","author":"RS Cvetkovi\u0107","year":"2005","unstructured":"Cvetkovi\u0107, R. S., & Scott, L. J. (2005). Dexrazoxane: A review of its use for cardioprotection during anthracycline chemotherapy. Drugs, 65(7), 1005\u20131024. https:\/\/doi.org\/10.2165\/00003495-200565070-00008","journal-title":"Drugs"},{"issue":"5","key":"10167_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14050930","volume":"14","author":"TA George","year":"2022","unstructured":"George, T. A., Hsu, C.-C., Meeson, A., & Lundy, D. J. (2022). Nanocarrier-based targeted therapies for myocardial infarction. Pharmaceutics, 14(5), Article 930. https:\/\/doi.org\/10.3390\/pharmaceutics14050930","journal-title":"Pharmaceutics"},{"issue":"1","key":"10167_CR108","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12964-026-02673-x","volume":"24","author":"M Li","year":"2026","unstructured":"Li, M., Zhang, Y., Hu, Y., Qin, Y., Zheng, Y., Lv, S., & Zhang, J. (2026). Mitochondrial homeostasis meets novel programmed cell death: Crosstalk mechanisms underlying cardiovascular diseases progression. Cell Communication and Signaling, 24(1), 100. https:\/\/doi.org\/10.1186\/s12964-026-02673-x","journal-title":"Cell Communication and Signaling"},{"issue":"22","key":"10167_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/polym13223969","volume":"13","author":"M Hruby","year":"2021","unstructured":"Hruby, M., Mart\u00ednez, I. I. S., Stephan, H., Pouckova, P., Benes, J., & Stepanek, P. (2021). Chelators for treatment of iron and copper overload: Shift from low-molecular-weight compounds to polymers. Polymers, 13(22), Article 3969. https:\/\/doi.org\/10.3390\/polym13223969","journal-title":"Polymers"},{"issue":"S1","key":"10167_CR110","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1017\/S0007114507833046","volume":"98","author":"C Mu\u00f1oz","year":"2007","unstructured":"Mu\u00f1oz, C., Rios, E., Olivos, J., Brunser, O., & Olivares, M. (2007). Iron, copper and immunocompetence. British Journal of Nutrition, 98(S1), S24\u2013S28. https:\/\/doi.org\/10.1017\/S0007114507833046","journal-title":"British Journal of Nutrition"},{"issue":"2","key":"10167_CR111","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2174\/0929867324666170920155439","volume":"26","author":"H Jansov\u00e1","year":"2019","unstructured":"Jansov\u00e1, H., & \u0160im\u016fnek, T. (2019). Cardioprotective potential of iron chelators and prochelators. Current Medicinal Chemistry, 26(2), 288\u2013301. https:\/\/doi.org\/10.2174\/0929867324666170920155439","journal-title":"Current Medicinal Chemistry"},{"issue":"11","key":"10167_CR112","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.tem.2021.08.004","volume":"32","author":"AJ Monteith","year":"2021","unstructured":"Monteith, A. J., & Skaar, E. P. (2021). The impact of metal availability on immune function during infection. Trends in Endocrinology and Metabolism: TEM, 32(11), 916\u2013928. https:\/\/doi.org\/10.1016\/j.tem.2021.08.004","journal-title":"Trends in Endocrinology and Metabolism: TEM"},{"issue":"21","key":"10167_CR113","doi-asserted-by":"publisher","first-page":"7889","DOI":"10.3390\/ijms21217889","volume":"21","author":"T Ravingerov\u00e1","year":"2020","unstructured":"Ravingerov\u00e1, T., Kindernay, L., Bartekov\u00e1, M., Ferko, M., Adameov\u00e1, A., Zohdi, V., Bern\u00e1tov\u00e1, I., Ferenczyov\u00e1, K., & Lazou, A. (2020). The molecular mechanisms of iron metabolism and its role in cardiac dysfunction and cardioprotection. International Journal of Molecular Sciences, 21(21), 7889. https:\/\/doi.org\/10.3390\/ijms21217889","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"10167_CR114","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.3390\/ijerph7072745","volume":"7","author":"SJS Flora","year":"2010","unstructured":"Flora, S. J. S., & Pachauri, V. (2010). Chelation in metal intoxication. International Journal of Environmental Research and Public Health, 7(7), 2745\u20132788. https:\/\/doi.org\/10.3390\/ijerph7072745","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10167_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030700","author":"Y Liu","year":"2022","unstructured":"Liu, Y., & Miao, J. (2022). An emerging role of defective copper metabolism in heart disease. Nutrients. https:\/\/doi.org\/10.3390\/nu14030700","journal-title":"Nutrients"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10167-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10167-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10167-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:18:59Z","timestamp":1787066339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-026-10167-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":115,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10167"],"URL":"https:\/\/doi.org\/10.1007\/s12012-026-10167-y","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"89"}}